Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.570
-0.100 (-3.75%)
Apr 24, 2026, 4:00 PM EDT - Market closed
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $185.59 million as of April 24, 2026. Its market cap has increased by 189.04% in one year.
Market Cap
185.59M
Enterprise Value
100.03M
1-Year Change
189.04%
Ranking
Category
Stock Price
$2.57
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $185.59M, a decrease of -69.99%. That is a compound annual growth rate of -22.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 185.59M | 45.21% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | 618.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Karyopharm Therapeutics | 195.23M |
| Canton Strategic Holdings | 193.20M |
| Sagimet Biosciences | 190.95M |
| Whitehawk Therapeutics | 190.20M |
| Korro Bio | 185.91M |
| Unicycive Therapeutics | 183.98M |
| Precision BioSciences | 181.65M |
| Tonix Pharmaceuticals Holding | 179.13M |